87 related articles for article (PubMed ID: 1605167)
1. Increased tyrosine protein kinase activity in hairy cell and monocytic leukemias.
Lower EE; Franco RS; Martelo OJ
Am J Med Sci; 1992 Jun; 303(6):387-91. PubMed ID: 1605167
[TBL] [Abstract][Full Text] [Related]
2. Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kuratsune H; Owada MK; Tokumine Y; Tagawa S; Nojima J; Shibano M; Nishimori Y; Morita T; Machii T; Kitani T
Leukemia; 1990 Oct; 4(10):700-3. PubMed ID: 2214873
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine protein kinases and their substrates in human leukemia cells.
Wickremasinghe RG; Piga A; Mire AR; Taheri MR; Yaxley JC; Hoffbrand AV
Leuk Res; 1985; 9(12):1443-50. PubMed ID: 4079454
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine protein kinase activity in normal and leukaemic human blood cells.
Punt CJ; Rijksen G; Vlug AM; Dekker AW; Staal GE
Br J Haematol; 1989 Sep; 73(1):51-6. PubMed ID: 2803978
[TBL] [Abstract][Full Text] [Related]
5. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptides reproducing the EGF-receptor segment homologous to the pp60v-src phosphoacceptor site. Phosphorylation by tyrosine protein kinases.
Cola C; Brunati AM; Borin G; Ruzza P; Calderan A; De Castiglione R; Pinna LA
Biochim Biophys Acta; 1989 Jul; 1012(2):191-5. PubMed ID: 2500978
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic and immunohistochemical evaluation of tyrosine phosphorylation in breast cancer specimens.
Lower EE; Franco RS; Miller MA; Martelo OJ
Breast Cancer Res Treat; 1993; 26(3):217-24. PubMed ID: 7504533
[TBL] [Abstract][Full Text] [Related]
8. [The effects of genistein on tyrosine protein kinase-mitogen activated protein kinase signal transduction pathway in hypertrophic scar fibroblasts].
Cao C; Li SR; Dai X; Chen YQ; Feng Z; Qin X; Zhao Y; Wu J
Zhonghua Shao Shang Za Zhi; 2008 Apr; 24(2):118-21. PubMed ID: 18785412
[TBL] [Abstract][Full Text] [Related]
9. Association of specific tyrosine phosphorylation with stages of B-cell differentiation in human lymphoid leukemias.
Kuratsune H; Owada K; Machii T; Nishimori Y; Ueda E; Tokumine Y; Tagawa S; Taniguchi N; Fujio H; Kitani T
Biochem Biophys Res Commun; 1985 Dec; 133(2):598-607. PubMed ID: 3878711
[TBL] [Abstract][Full Text] [Related]
10. Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors.
Trentin L; Pizzolo G; Zambello R; Agostini C; Morosato L; Sancetta R; Adami F; Vinante F; Chilosi M; Gallati H
Leukemia; 1995 Jun; 9(6):1051-5. PubMed ID: 7596168
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of 2-chlorodeoxyadenosine (CdA) in extracts of peripheral blood mononuclear cells of leukaemic patients.
Arnér ES; Spasokoukotskaja T; Juliusson G; Liliemark J; Eriksson S
Br J Haematol; 1994 Aug; 87(4):715-8. PubMed ID: 7986711
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical phosphorylation of a 50-kDa protein by protein tyrosine kinases TPK-IIB and C-Fgr, and its identification as HS1 hematopoietic-lineage cell-specific protein.
Brunati AM; Ruzzene M; James P; Guerra B; Pinna LA
Eur J Biochem; 1995 Apr; 229(1):164-70. PubMed ID: 7744027
[TBL] [Abstract][Full Text] [Related]
13. Myeloid differentiation associated tyrosine protein kinase activity in WEHI-3B murine monomyelocytic leukemia cells.
DiGiovanna MP; Sartorelli AC
Leukemia; 1991 Oct; 5(10):869-78. PubMed ID: 1720491
[TBL] [Abstract][Full Text] [Related]
14. Expression of three major protein kinase C isozymes in various types of human leukemic cells.
Komada F; Nishikawa M; Uemura Y; Morita K; Hidaka H; Shirakawa S
Cancer Res; 1991 Aug; 51(16):4271-8. PubMed ID: 1868447
[TBL] [Abstract][Full Text] [Related]
15. Net increase of platelet membrane tyrosine specific-protein kinase activity by phorbol myristate acetate.
Ishihara N; Sakamoto H; Iwama M; Kobayashi B
Life Sci; 1990; 46(1):29-36. PubMed ID: 2299969
[TBL] [Abstract][Full Text] [Related]
16. Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Babusíková O; Hrivnáková A; Klobusická M; Mesárosová A; Ujházy P
Neoplasma; 1990; 37(6):693-701. PubMed ID: 2125699
[TBL] [Abstract][Full Text] [Related]
17. Different specificities of spleen tyrosine protein kinases for synthetic peptide substrates.
Donella-Deana A; Brunati AM; Marchiori F; Borin G; Marin O; Pinna LA
Eur J Biochem; 1990 Dec; 194(3):773-7. PubMed ID: 2269299
[TBL] [Abstract][Full Text] [Related]
18. Detection of tyrosine protein kinase substrates in fresh leukemia cells and normal blood cells using an immunoblotting technique.
Evans JP; Wickremasinghe RG; Hoffbrand AV
Leukemia; 1987 Nov; 1(11):782-5. PubMed ID: 3316858
[TBL] [Abstract][Full Text] [Related]
19. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
